Get started
Author

Chloé Herledan

Observed names: C Herledan, C. Herledan, Chloe Herledan, Chloé HERLEDAN, Chloé Herlédan, Herledan, Chloe
ORCID: 0000-0002-3170-4751
Observed ORCID: 0000-0002-3170-4751
OpenAlex ID: A5066590396
Real-life drug–drug and herb–drug interactions in outpatients taking oral anticancer drugs: comparison with databases
2021 · H. Prely, C. Herledan, et al. · Journal of Cancer Research and Clinical Oncology · 53
Clinical and economic impact of medication reconciliation in cancer patients: a systematic review
2020 · Chloé Herledan, Amandine Baudouin, et al. · Supportive Care in Cancer · 45
Impact of pharmaceutical care interventions on multidisciplinary care of older patients with cancer: A systematic review
2023 · Chloé Herledan, Marie-Anne Cerfon, et al. · Journal of Geriatric Oncology · 44
PDF
Clinical and economic impact of clinical oncology pharmacy in cancer patients receiving injectable anticancer treatments: a systematic review
2023 · Claire Lattard, Amandine Baudouin, et al. · Journal of Cancer Research and Clinical Oncology · 25
Thromboembolic events and thromboprophylaxis associated with immunomodulators in multiple myeloma patients: a real-life study
2021 · V. Leclerc, L. Karlin, et al. · Journal of Cancer Research and Clinical Oncology · 22
Clinical impact and cost‐saving analysis of a comprehensive pharmaceutical care intervention in older patients with cancer
2023 · Chloé Herledan, Claire Falandry, et al. · Journal of the American Geriatrics Society · 16
PDF
Enhancing collaboration between geriatricians, oncologists, and pharmacists to optimize medication therapy in older adults with cancer: A position paper from SOFOG-SFPO
2023 · Chloé Herledan, Anne Toulemonde, et al. · Critical Reviews in Oncology/Hematology · 16
PDF
Medication assessment in older adults with cancer – Current practices in clinical pharmacy
2023 · Darren J. Walsh, Kavita Kantilal, et al. · Journal of Geriatric Oncology · 16
PDF
Economic impact of clinical pharmaceutical activities in hospital wards: A systematic review
2020 · Amandine Baudouin, Chloé Herledan, et al. · Research in Social and Administrative Pharmacy · 15
PDF
Immunosuppression medication adherence after allogeneic hematopoietic stem cell transplant: Impact of a specialized clinical pharmacy program
2021 · Florent Charra, Michael Philippe, et al. · Journal of Oncology Pharmacy Practice · 13
Comparing different robots available in the European market for the preparation of injectable chemotherapy and recommendations to users
2022 · Ariane Cerutti, Thomas Ledoux, et al. · Journal of Oncology Pharmacy Practice · 11
Real-world experience with CDK4-6 inhibition in the old and oldest old with a diagnosis of breast cancer
2024 · Paula Sobrini-Morillo, Christine Ravot, et al. · Seminars in Oncology · 10
Early follow-up of outpatients with oral anticancer therapy in the ONCORAL multidisciplinary community-hospital program
2024 · Claire Lattard, Chloé Herledan, et al. · The Oncologist · 9
PDF
Assessment of Patient Reported Outcomes (PROs) in Outpatients Taking Oral Anticancer Drugs Included in the Real-Life Oncoral Program
2022 · Bastien Collomb, Amélie Dubromel, et al. · Cancers · 9
PDF
Immunomodulatory drugs in multiple myeloma: Impact of the SCARMET (Self CARe and MEdication Toxicity) educational intervention on outpatients’ knowledge to manage adverse effects
2020 · Juliette Périchou, Florence Ranchon, et al. · PLoS ONE · 9
PDF
Drug cost savings in phase III hematological oncology clinical trials in a university hospital
2020 · Chloé Herledan, Florence Ranchon, et al. · Hematological Oncology · 9
Feasibility of a screening and prevention procedure for risks associated with dysphagia in older patients in geriatric units: the DYSPHAGING pilot study protocol
2024 · Olivier Durlach, Stéphanie Tripoz-dit-Masson, et al. · BMJ Open · 5
PDF
Introduction du PICC-Line au sein d’un centre hospitalo-universitaire : bilan après deux ans d’expérience
2016 · Carole Serrano, J. Bataille, et al. · Journal de Pharmacie Clinique · 4
Cost-effectiveness of the ONCORAL multidisciplinary programme for the management of outpatients taking oral anticancer agents at risk of drug-related event: protocol for a pragmatic randomised controlled study
2024 · Laure Huot, Pascale Guerre, et al. · BMJ Open · 3
PDF
Cancer outpatients during the COVID-19 pandemic: what Oncoral has to teach us about medical drug use and the perception of telemedicine
2023 · V. Larbre, N. Romain-Scelle, et al. · Journal of Cancer Research and Clinical Oncology · 3
PDF
Medication Reconciliation and Review to Prevent Medication Errors in Elderly Cancer Patients
2019 · C. Herledan, A. Baudouin, et al. · Journal of Geriatric Oncology · 3
Oncoral Follow-Up for Outpatients Treated with Oral Anticancer Drugs Assessed by Relative Dose Intensity
2025 · Virginie Larbre, Florence Ranchon, et al. · Pharmaceuticals · 2
PDF
Intravenous route for folate supplementation in a patient with celiac disease treated by pemetrexed-based chemotherapy for non-small-cell lung cancer
2022 · Marie Beaurain, Catherine Rioufol, et al. · Journal of Oncology Pharmacy Practice · 2
The educational needs of pharmacists to optimize medication usage in older adults with cancer: A scoping review by the International Society of Geriatric Oncology Nursing, Allied Health, and Scientists pharmacy group
2026 · Kavita Kantilal, Darren J. Walsh, et al. · Journal of Geriatric Oncology · 1
Impact of the oncoral patient education follow-up program on the acquisition of knowledge about oral anticancer drugs
2026 · Virginie Larbre, Nicolas Romain Scelle, et al. · Journal of Oncology Pharmacy Practice · 1
Works count: 51
Citation count: 348
H-index: 11
I10-index: 12
Year
Topic
Type